About Vance Warren

Delivering Specialized Early-Phase Clinical Science, Monitoring, and Operations Support.

Microscope and glassware in laboratory setting

Specialized Clinical Science Services

Vance Warren Clinical Science Ops Consulting is a purpose-built consultancy dedicated to early-phase clinical development, specifically Phase 1 through Phase 1b trials. The focus is simple and critical: ensure participant safety, maintain data integrity, and support high-stakes decision-making in fast-moving development environments.

Deep Industry Experience

With over 30 years of experience across leading global organizations, including AstraZeneca, Novartis, Daiichi-Sankyo, and Bristol Myers Squibb, the consultancy brings deep sponsor-side and CRO fluency to every engagement. Operations are structured to support programs across the United States and Asia-Pacific, enabling seamless collaboration across regions and time zones.

Scientist writing notes in laboratory

What Defines My Approach

Fast timing concept icon

Purpose-Built for Urgent and Rescue Scenarios

Designed to step into complex, high-pressure situations where timelines are tight and execution must be precise. 

Shield emblem indicating safety approval

Safety-First Execution

Every study is approached with participant safety as the primary priority, supported by rigorous oversight and proactive risk identification.

Search and verify symbol on teal background

Inspection-Ready by Design

Documentation, processes, and oversight are structured to meet regulatory expectations at every stage of the clinical trial lifecycle.

Medical data on computer screen icon

Data Integrity and Decision Support

Focused on generating reliable PK/PD data and translating it into meaningful insights for clinical and operational teams.

My Capabilities

Medical team reviewing information on a tablet

Clinical Science

Comprehensive scientific leadership across early-phase development:

  • Study design support for FIH (SAD, MAD), clinical pharmacology, and Phase 1b trials
  • PK/PD strategy and dose escalation planning
  • Protocol, ICF, and CSR clinical section authoring and review
  • Clinical data review, trend analysis, and decision support
  • Collaboration with preclinical and nonclinical teams
  • Scientific liaison across CRO, sites and sponsor stakeholders
  • Contribution to broader drug development strategy when required
Medical professional reviewing MRI results

Clinical Monitoring (CRA)

Focused oversight aligned with early-phase best practices:

  • Risk-based monitoring in accordance with ICH-GCP
  • Support for SQV, SIV, IMV, and COV activities
  • Site and vendor training tailored to Phase 1 workflows
  • Issue escalation and CAPA management
  • Continuous focus on documentation quality and inspection readiness
Surgical team performing an operation

Clinical Operations

End-to-end operational leadership for Phase 1 studies:

  • Full lifecycle study management from startup through database lock and CSR support
  • Conduct RFP review, assist with interrogations of bid defense, including CRO and clinicial pharmacology unit selection
  • Timeline and budget oversight
  • Sample logistics management, including coordination of PK/PD reconciliation
  • Vendor oversight across labs and specialty providers
  • KPI tracking and risk management

Phase 1 Study Focus

Expertise spans a wide range of early-phase study types:

  • Healthy volunteer and patient-based Phase 1–1b trials
  • First-in-human (FIH), single ascending dose (SAD), and multiple ascending dose (MAD) studies
  • Drug-drug interaction (DDI), food effect, rBA/BE, and TQTc studies
  • Human ADME studies
  • Special populations, including renal and hepatic impairment
  • Ethnic bridging studies
Doctors discussing patient information
Team of doctors discussing medical research

Engagement Model

Flexible models designed to integrate seamlessly with sponsor teams:

  • Extension of your internal early-phase development team

  • Fully outsourced Phase 1 function when required

  • Strategic partner model for ongoing collaboration

  • Single-study support for targeted needs

  • Coverage across the United States and APEC member countries

Global Presence

Operational reach across key clinical development regions:

  • Asia-Pacific, including APEC member countries

With established presences in Union, New Jersey, and Bangkok, Thailand, projects are supported with regional expertise and global coordination.

Bring Clarity and Control to Your Early-Phase Program

Organizations seeking specialized early-phase expertise can initiate collaboration directly. Partner with a clinical science expert built for precision, speed, and high-stakes execution.

Start Your Interrogation
Healthcare team in hallway discussion